News
Common Sense Oncology has developed principles designed to improve randomized phase 3 trials and ensure meaningful results. Recommendations address use of certain endpoints, toxicity reporting and ...
The phase 3 programme will be conduced across approximately 200 investigation sites, eventually enrolling around 1,800 patients, and should generate results in 2024, according to Grünenthal's ...
Bayer is pressing ahead with a phase 3 trial of its oral Factor XIa inhibitor asundexian, a new anticoagulant, despite missing efficacy targets in two mid-stage studies. The OCEANIC trial ...
WASHINGTON – For Harvard University, the cavalry has arrived. When the nation’s oldest and richest college first rebuked the Trump administration last Monday amid efforts to force changes to ...
Their three biggest needs could be at positions with the most value when they're on the clock at picks 10, 39, and 41. According to NFL Mock Draft Database, the Bears' consensus team needs based ...
See what moon phase it is tonight and find out when you can see the rest of the moon phases for 2025. Today, April 22, 2025, the moon is 24 days old and is in the Waning Crescent phase of its ...
The 2024/25 UEFA Champions League kicked off on 17 September and runs to the final in Munich on 31 May, with the best of the best doing battle once again to be crowned the elite side in Europe.
Apr 19, 2025 Apr 19, 2025 Updated 8 mins ago ...
Enriqueta Felip, MD, PhD, the Universitat Autònoma de Barcelona, Spain, section chief at the Vall d'Hebron University Hospital, head of the Vall d' Hebron Institute of Oncology's thoracic tumors group ...
Kennedy Jr., the health secretary, will direct food manufacturers to phase out eight petroleum-based food dyes that ... which regulates about 80% of the nation’s food supply, banned Red Dye No. 3 ...
SHiFT codes in Borderlands 3 help you get everything from Golden and Diamond Keys to custom skins – and new ones are pretty regularly released to use in-game. Like its predecessors and Tiny Tina ...
Gilead’s antibody-drug conjugate Trodelvy combined with Merck’s Keytruda reduced the risk of disease progression or death in a key study of an aggressive form of … ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results